FIG. 1.
Bar graph indicating the extent to which primary protease inhibitor resistance mutations present at baseline (gray bars) were also present following salvage therapy (black bars).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.